|
Volumn 31, Issue 5, 2013, Pages 365-
|
Do no harm
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HLA A ANTIGEN;
MAGNETIC NANOPARTICLE;
TUMOR ANTIGEN;
ADOPTIVE IMMUNOTHERAPY;
ADOPTIVE T CELL THERAPY;
ANTIGEN EXPRESSION;
ANTIGEN PRESENTATION;
CANCER THERAPY;
CELL THERAPY;
COLON CANCER;
CROSS REACTION;
EDITORIAL;
FOLLOW UP;
IN VITRO STUDY;
MEMORY T LYMPHOCYTE;
PRIORITY JOURNAL;
SINGLE NUCLEOTIDE POLYMORPHISM;
T LYMPHOCYTE;
VIRAL GENE DELIVERY SYSTEM;
ANTIGENS, NEOPLASM;
CLINICAL TRIALS AS TOPIC;
EVIDENCE-BASED MEDICINE;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
NEOPLASMS;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
EID: 84877360207
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2587 Document Type: Editorial |
Times cited : (6)
|
References (0)
|